StockMarketWire.com - AstraZeneca and Oxford University reportedly paused their Covid-19 vaccine study after a UK participant in the trial suffered a suspected serious adverse reaction, according to Stat News.

AstraZeneca, in a statement to Stat News, described the pause as a 'routine action' in the case of 'an unexplained illness.'

The company also said it would expedite the review to minimise any potential impact on the trial timeline.

At 8:00am: [LON:AZN] Astrazeneca PLC share price was 0p at 8348p



Story provided by StockMarketWire.com